Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05642793

Effect of Postvitrectomy Proactive Use of Conbercept on Postoperative Complications in PDR Patients

Conditions: Proliferative Diabetic Retinopathy

Sex: All
Ages: 19 Years – 70 Years
Phase: PHASE2
Enrollment: 80
Sponsor: Peking University Third Hospital

Location: China

Summary

This is an unmasking randomized clinical trial. the main purpose of this study is to analyze whether posvitrectomy proactive use of conbercept can reduce the rate of postoperative complication in PDR patients.

Eligibility Criteria

Inclusion Criteria:PDR patients undergoing vitrectomyExclusion Criteria:patients who had received intravitreal injection or systemic use of all types of anti-VEGF agents in the recent three months before vitrectomypatients who had received intravitreal injection or systemic use of all types of steroid in the recent one month before vitrectomypatients who had received complete PRP before vitrectomypatients who are pregnant

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05642793). StuddyBuddy aggregates publicly available trial information.